We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.57%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$3.15B
AUM Growth
+$16.9M
Cap. Flow
-$33.7M
Cap. Flow %
-1.07%
Top 10 Hldgs %
42.21%
Holding
106
New
27
Increased
26
Reduced
18
Closed
18

Top Buys

Rank Stock Value
1
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
+$103M
2
VTRS icon
Viatris
VTRS
+$76.6M
3
PCRX icon
Pacira BioSciences
PCRX
+$67.6M
4
BKD icon
Brookdale Senior Living
BKD
+$65.1M
5
ABMD
Abiomed Inc
ABMD
+$62.4M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$79.8M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$71.3M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$66.5M
4
HUM icon
Humana
HUM
+$30.1M
5
BOLD
Audentes Therapeutics, Inc
BOLD
+$29.6M

Sector Composition

Rank Sector Weight
1 Healthcare 71.83%
2 Technology 0.07%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD
26
DELISTED
Amicus Therapeutics
FOLD
$30.1M 0.95%
+3,253,960
New +$30.9M
CNST
27
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$30M 0.95%
954,100
+404,100
+73% +$14M
BPMC
28
DELISTED
Blueprint Medicines
BPMC
$26.8M 0.85%
457,968
-106,946
-19% -$6.88M
TNDM icon
29
Tandem Diabetes Care
TNDM
$1.18B
$26.6M 0.84%
412,867
-948,478
-70% -$66.5M
RETA
30
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$26.5M 0.84%
183,865
+83,865
+84% +$16.2M
DCPH
31
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$24.3M 0.77%
589,485
+281,485
+91% +$15.6M
MCK icon
32
McKesson
MCK
$99.5B
$23.7M 0.75%
+175,437
New +$25.7M
BDSI
33
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$23.4M 0.74%
+6,184,243
New +$30.4M
DXCM icon
34
DexCom
DXCM
$28.3B
$23.4M 0.74%
+348,000
New +$21.7M
RCKT icon
35
Rocket Pharmaceuticals
RCKT
$355M
$23.4M 0.74%
1,677,367
-487,104
-23% -$9.65M
MOH icon
36
Molina Healthcare
MOH
$10.4B
$23.1M 0.73%
165,000
+16,567
+11% +$2.22M
SRPT icon
37
Sarepta Therapeutics
SRPT
$1.68B
$23M 0.73%
235,000
+25,000
+12% +$2.86M
EDIT icon
38
Editas Medicine
EDIT
$411M
$23M 0.73%
1,158,841
– –
SWTX
39
DELISTED
SpringWorks Therapeutics
SWTX
$21.3M 0.68%
788,243
– –
DBVT
40
DBV Technologies
DBVT
$823M
$20.4M 0.65%
520,969
+45,369
+10% +$4.07M
ADVM
41
DELISTED
Adverum Biotechnologies
ADVM
$20.3M 0.64%
207,500
+186,366
+882% +$21.7M
ARGX icon
42
argenx
ARGX
$55.6B
$20M 0.63%
151,779
-32,221
-18% -$4.72M
MRTX
43
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$18.6M 0.59%
242,200
+68,200
+39% +$6.12M
TPTX
44
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$18.5M 0.59%
413,321
+47,321
+13% +$2.51M
ARDX icon
45
Ardelyx
ARDX
$1.25B
$17.5M 0.56%
3,083,000
-3,921,253
-56% -$26.7M
TECX
46
Tectonic Therapeutic
TECX
$578M
$17.5M 0.56%
93,740
-3,341
-3% -$787K
KRRO icon
47
Korro Bio
KRRO
$155M
$16.8M 0.53%
18,914
-9,459
-33% -$10.2M
MYOK
48
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$16.2M 0.52%
346,409
-442,591
-56% -$28.4M
GKOS icon
49
Glaukos
GKOS
$8.92B
$16M 0.51%
+517,982
New +$26.6M
SEM
50
DELISTED
Select Medical
SEM
$15.9M 0.51%
1,972,928
+500,749
+34% +$5.95M
1
2
3 4

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2020 Portfolio in Review

As of Q1 2020, Deerfield Management held 106 positions worth $3.15B, up 0.54% from $3.13B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Deerfield Management's Q1 2020 filing shows 27 new, 26 increased, 18 reduced and 18 closed positions. Its largest new stake was DFP Healthcare Acquisitions Corp. Unit: 10,460,000 shares worth $103M. The largest sale was Acceleron Pharma, an estimated $79.8M.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 78% a quarter earlier, followed by Technology and Financials.

  • Deerfield Management's largest Q1 2020 buy was DFP Healthcare Acquisitions Corp. Unit: 10,460,000 shares worth $103M.
  • Deerfield Management added most to Viatris in Q1 2020, an estimated $76.6M increase.
  • Deerfield Management's biggest Q1 2020 reduction was Acceleron Pharma, cutting an estimated $79.8M.
  • Deerfield Management fully exited Ra Pharmaceuticals, Inc. Common Stock in Q1 2020, selling an estimated $71.3M.
  • Deerfield Management's ten largest holdings make up 42% of its $3.15B portfolio in Q1 2020.
  • Deerfield Management opened 27 new positions and closed 18 in Q1 2020.
  • Deerfield Management's portfolio value rose 0.54% quarter-over-quarter to $3.15B.

Based on Deerfield Management's 13F filing for Q1 2020, filed 15 May 2020.